China Health Group Inc. (8225.HK)
HKD 0.15
(5.56%)
HKD 0.15
(5.56%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.21 Million CNY | 42.99% |
| 2022 | 5.74 Million CNY | -91.01% |
| 2021 | 63.85 Million CNY | -4.63% |
| 2020 | 66.95 Million CNY | 25.24% |
| 2019 | 53.46 Million CNY | 2.1% |
| 2018 | 52.36 Million CNY | -7.18% |
| 2017 | 56.41 Million CNY | 234.14% |
| 2016 | 16.88 Million CNY | 8.81% |
| 2015 | 15.51 Million CNY | 434.88% |
| 2014 | 2.9 Million CNY | 155.99% |
| 2013 | -5.18 Million CNY | -141.61% |
| 2012 | 12.45 Million CNY | 77.76% |
| 2011 | 7 Million CNY | -67.22% |
| 2010 | 21.37 Million CNY | -19.76% |
| 2009 | 26.63 Million CNY | 73.15% |
| 2008 | 15.38 Million CNY | -33.0% |
| 2007 | 22.95 Million CNY | -28.89% |
| 2006 | 32.28 Million CNY | 46.51% |
| 2005 | 22.03 Million CNY | 17.42% |
| 2004 | 18.76 Million CNY | -34.08% |
| 2003 | 28.46 Million CNY | 23.37% |
| 2002 | 23.07 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | -2.95 Million CNY | -299.26% |
| 2023 FY | 8.21 Million CNY | 42.99% |
| 2023 Q1 | 2.97 Million CNY | 116.12% |
| 2023 Q2 | 6.71 Million CNY | 125.47% |
| 2023 Q3 | 1.48 Million CNY | -77.87% |
| 2022 FY | 5.74 Million CNY | -91.01% |
| 2022 Q2 | 12.04 Million CNY | 13.61% |
| 2022 Q3 | 1.57 Million CNY | -86.95% |
| 2022 Q4 | -18.46 Million CNY | -1275.43% |
| 2022 Q1 | 10.59 Million CNY | -46.46% |
| 2021 Q4 | 19.79 Million CNY | 246.7% |
| 2021 FY | 63.85 Million CNY | -4.63% |
| 2021 Q1 | 19.67 Million CNY | -30.59% |
| 2021 Q2 | 18.68 Million CNY | -5.0% |
| 2021 Q3 | 5.7 Million CNY | -69.45% |
| 2020 Q4 | 28.33 Million CNY | 393.76% |
| 2020 Q3 | 5.73 Million CNY | -65.13% |
| 2020 Q2 | 16.45 Million CNY | 0.19% |
| 2020 FY | 66.95 Million CNY | 25.24% |
| 2020 Q1 | 16.42 Million CNY | -30.46% |
| 2019 Q4 | 23.62 Million CNY | 445.42% |
| 2019 Q2 | 13.06 Million CNY | 4.9% |
| 2019 Q1 | 12.45 Million CNY | -46.05% |
| 2019 Q3 | 4.33 Million CNY | -66.84% |
| 2019 FY | 53.46 Million CNY | 2.1% |
| 2018 FY | 52.36 Million CNY | -7.18% |
| 2018 Q4 | 23.07 Million CNY | 500.52% |
| 2018 Q3 | 3.84 Million CNY | -73.14% |
| 2018 Q2 | 14.3 Million CNY | 28.49% |
| 2018 Q1 | 11.13 Million CNY | -67.8% |
| 2017 FY | 56.41 Million CNY | 234.14% |
| 2017 Q3 | 9.46 Million CNY | 75.09% |
| 2017 Q4 | 34.57 Million CNY | 265.53% |
| 2017 Q2 | 5.4 Million CNY | -22.53% |
| 2017 Q1 | 6.97 Million CNY | 120.7% |
| 2016 Q2 | 5.67 Million CNY | -8.48% |
| 2016 FY | 16.88 Million CNY | 8.81% |
| 2016 Q4 | 3.16 Million CNY | 70.81% |
| 2016 Q1 | 6.2 Million CNY | -44.96% |
| 2016 Q3 | 1.85 Million CNY | -67.4% |
| 2015 Q4 | 11.26 Million CNY | 820.34% |
| 2015 Q1 | 665 Thousand CNY | 134.31% |
| 2015 FY | 15.51 Million CNY | 434.88% |
| 2015 Q2 | 2.36 Million CNY | 255.34% |
| 2015 Q3 | 1.22 Million CNY | -48.2% |
| 2014 Q1 | 984 Thousand CNY | 111.51% |
| 2014 FY | 2.9 Million CNY | 155.99% |
| 2014 Q3 | 751 Thousand CNY | 62.91% |
| 2014 Q2 | 461 Thousand CNY | -53.15% |
| 2014 Q4 | -1.93 Million CNY | -358.06% |
| 2013 Q3 | 249 Thousand CNY | 149.0% |
| 2013 Q1 | 3.01 Million CNY | 172.62% |
| 2013 FY | -5.18 Million CNY | -141.61% |
| 2013 Q4 | -8.54 Million CNY | -3533.33% |
| 2013 Q2 | 100 Thousand CNY | -96.69% |
| 2012 Q4 | -4.15 Million CNY | -259.88% |
| 2012 FY | 12.45 Million CNY | 77.76% |
| 2012 Q3 | 2.6 Million CNY | 0.0% |
| 2011 Q2 | 5.17 Million CNY | 0.0% |
| 2011 Q4 | -8.86 Million CNY | -279.11% |
| 2011 FY | 7 Million CNY | -67.22% |
| 2011 Q3 | 4.94 Million CNY | -4.27% |
| 2010 FY | 21.37 Million CNY | -19.76% |
| 2010 Q1 | 5.2 Million CNY | -49.54% |
| 2010 Q2 | 4.92 Million CNY | -5.44% |
| 2010 Q3 | 4.91 Million CNY | -0.08% |
| 2010 Q4 | 6.32 Million CNY | 28.61% |
| 2009 Q2 | 3.53 Million CNY | 0.0% |
| 2009 FY | 26.63 Million CNY | 73.15% |
| 2009 Q3 | 8.22 Million CNY | 132.6% |
| 2009 Q4 | 10.31 Million CNY | 25.38% |
| 2008 FY | 15.38 Million CNY | -33.0% |
| 2007 FY | 22.95 Million CNY | -28.89% |
| 2006 FY | 32.28 Million CNY | 46.51% |
| 2005 FY | 22.03 Million CNY | 17.42% |
| 2004 FY | 18.76 Million CNY | -34.08% |
| 2003 FY | 28.46 Million CNY | 23.37% |
| 2002 FY | 23.07 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Life Healthcare Group Limited | 37.78 Million HKD | 78.269% |
| China Biotech Services Holdings Limited | 34.32 Million HKD | 76.075% |